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Objective: The best combination of questions to define asthma in epidemiological asthma studies is not known.
We summarized the operational definitions of asthma used in prevalence studies and empirically assess how
asthma prevalence estimates vary depending on the definition used.
Methods: We searched the Thomson Reuters ISI Web of knowledge and included (1) cross-sectional studies (2) on
asthma prevalence (3) conducted in the general population and (4) containing an explicit definition of asthma. The
search was limited to the 100 most-cited papers or published since January 2010. For each paper, we recorded the
asthma definition used and other variables. Then we applied the definitions to the data of the Portuguese National
Asthma survey (INAsma) and of the 2005–2006 National Health and Nutrition Examination Survey (NHANES)
computing asthma prevalence estimates for the different definitions.
Results: Of 1738 papers retrieved, 117 were included for analysis. Lifetime asthma, diagnosed asthma and current
asthma were defined in 8, 12 and 29 different ways, respectively. By applying definitions of current asthma on
INAsma and NHANES data, the prevalence ranged between 5.3%-24.4% and 1.1%-17.2%, respectively.
Conclusions: There is considerable heterogeneity in the definitions of asthma used in epidemiological studies leading
to highly variable estimates of asthma prevalence. Studies to inform a standardized operational definition are needed.
Meanwhile, we propose a set of questions to be reported when defining asthma in epidemiological studies.
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The World Health Organization recommends assessing
population needs concerning chronic respiratory diseases
to better define adequate health policies [1]. Epidemio-
logical studies at a population level, and prevalence studies
in particular, are essential for this purpose.
The main multinational studies on asthma prevalence
are the European Community Respiratory Health Survey
(ECRHS) in adults [2], and the International Study of
Asthma and Allergies in Childhood (ISAAC) in children
and adolescents [3]. The European Union–funded Global
Allergy and Asthma European Network (GA2LEN) re-
cently conducted a large survey on the prevalence of* Correspondence: jfonseca@med.up.pt
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unless otherwise stated.airway and allergic diseases, built mainly on the questions
and definitions used in the ECRHS [4].
Although the definitions used to diagnose asthma has a
great impact on prevalence estimates [5], a standardized
operational definition of asthma is still lacking. Asthma
should ideally be defined by a combination of symptoms,
clinical diagnosis, pulmonary function tests and studies of
either bronchial hyperresponsiveness (BHR) or reversibil-
ity of airflow obstruction [6-8]. However, this is rarely
feasible. In fact, in the context of population studies, only
a few have combined the use of an initial symptoms ques-
tionnaire followed by clinical assessment including lung
function tests in subsamples of symptomatic and asymp-
tomatic individuals [2,3].
The aim of this paper is 1) to provide an overview of the
operational definitions of asthma used in recent prevalence
studies and 2) to empirically assess the impact of the defin-
ition used on the prevalence of asthma estimates using dataal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Inquérito Nacional sobre Asma (INAsma) [9] and Na-
tional Health and Nutrition Examination Survey (NHANES)
2005–2006 [10]. Based on this approach we propose a set of
questions to be used when defining asthma in epidemio-
logical studies, until a standardized operational definition
based on prospective data can be established.
Methods
Literature search strategy and inclusion criteria
We performed a systematic literature search of the
Thomson Reuters ISI Web of Knowledge. The initial
search targeted papers with the terms “asthma” and
“prevalence” in the title and the final selection included
(i) cross-sectional studies (ii) on asthma prevalence (iii)
conducted in the general population.
To have a comprehensive overview of the definitions of
asthma, with both the most recent definitions and mostFigure 1 Study selection. From the 1 738 papers retrieved from the Web
were finally included in the study.cited ones, we had two criteria in the papers selection: 1)
The search was limited to the studies published between
January 2010 and October 2013 and 2) the 100 most-cited
papers on the topic were included in the initial search
(Figure 1).
Papers written in languages other than English,
Portuguese, Spanish or French were excluded, as were
those without an explicit definition of asthma or with
definitions of asthma based on the International Classi-
fication of Diseases (ICD).
Data extraction from published studies
Papers were screened by a single author (AS-S) in two
phases (title and abstract and full-text screening) to ex-
clude duplicates and articles that did not meet the eligi-
bility criteria. Papers satisfying the inclusion criteria were
examined and data on country, number and age of partici-
pants, site of screening, questionnaire used, prevalenceof Knowledge using the terms asthma and prevalence in the title; 117
Figure 2 Elements of the definitions of “Current asthma” connected in the order established by each studies. Symptoms in the last
12 months are represented in blue, lung function tests in orange and physician diagnosis in green. The size of each element is proportional to
the number of definitions using the element. The color of the lines indicates the number of times each connection was used: once (blue), twice
(pink), three times (purple), four to eight times (red) and more than ten times (black). To simplify the diagram, breathlessness and dyspnea were
considered the same.
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of asthma were recorded on a purpose-designed
form. Doubts regarding the inclusion of papers and data
extraction were clarified in agreement with a second
investigator.Epidemiologic studies datasets
The Inquérito Nacional sobre Asma (INAsma) was con-
ducted in 2010 under the auspices of the Portuguese
Health Directorate and estimated a prevalence of current
asthma (defined as affirmative to the question “Have you
Table 1 Definitions of “current asthma” and prevalence estimates computed using data from INAsma survey (n = 6257)
and from NHANES 2009 (n = 10348)
Current asthma definition INAsma NHANES 05/06
% [95% CI] % [95% CI]
Ever had asthma and wheeze in the last 12 months [13] 9.3 [8.8-10.0] n.a.
Ever had asthma and this was confirmed by a physician and at least one in the
last 12 months: wheeze, waking with tightness in the chest, waking with
breathlessness, waking with cough [14]
8.5 [7.7-9.3]* n.a.
Ever had asthma and at least one of 3 symptoms in the last 12 months:
wheezing, waking with breathlessness or having an asthma attack [9]
10.3 [9.5-11.0] n.a.
Ever had asthma and still have asthma [15,16] n.a. n.a.
Ever had asthma and was this confirmed by a physician and wheeze
and/or taking medication(s) for asthma or wheezing in the past 12 months [17]
n.a. n.a.
At least one of the following: 1) Ever had asthma and was confirmed by
a doctor and still have asthma or 2) significant bronchodilator response
according to reversibility [18]
n.a. n.a.
Ever had asthma and still have asthma and was confirmed by a physician [19] n.a. n.a.
At least one of the following: 1) Ever had asthma and wheezing in the last 12 months
or 2) wheezing 4 times or more during the last 12 months or 3) physician diagnosis
and wheezing in the last 12 months or 4) current use of inhalation steroids [20]
n.a. n.a.
Diagnosed with asthma by a physician and wheeze in the last 12 months [21] 7.6 [6.9-8.3]* 1.7 [1.5-1.9]
Diagnosed with asthma by a physician and currently taking asthma medication [22] 7.4 [6.7-8.1]* 1.1 [0.9-1.3]
Diagnosed with asthma by a physician and use of asthma medication in the last
12 months and cough or wheeze in the last 12 months [23]
5.3 [4.7-5.9]† n.a.
Diagnosed with asthma by a physician and at least one: currently taking
asthma medication, attacks of shortness of breath or recurrent
wheeze in the last 12 months [24]
6.3 [5.6-6.0]*,‡ n.a.
Diagnosed with asthma by a physician and still have asthma [25-37] n.a. 8.4 [7.9-8.4]
Diagnosed with asthma by a physician and any of the following in the
previous 2 years: wheezing following a common cold, dyspneal feeling
at night or early in the morning, cough or wheeze during exercise [38]
n.a. n.a.
Physician stated that (you) had asthma in the last 2 years or on 2 or
more separate occasions had wheezing in the last 2 years [39,40]
n.a. n.a.
At least one of the following: 1) Diagnosed with asthma by a physician
and at least 1 symptom in the last 12 months: wheeze, wheezes with
attacks of shortness of breath, nocturnal attacks of shortness of breath,
use of asthma medication or 2) reversible airways obstruction [41]
n.a. n.a.
Wheeze in the last 12 months [42-54] 22.9 [21.9-23.9] 12.9 [12.2-13.5]
Wheeze in the last 12 months or currently taking asthma medication [55] 24.4 [23.3-25.5] 12.9 [12.2-13.5]
Current wheeze and 1 of the following: 1) ever had an asthma attack
or 2) ever had asthma or 3) taking medication(s) for asthma or wheeze [56]
9.3 [8.6-10.0]** n.a.
Asthma attack or currently taking asthma medication [2] 9.0 [8.3-9.7] n.a.
At least one in the last 12 months: Waking at night by shortness of breath,
had an asthma attack or currently taking any medicines (including inhalers,
aerosols or tablets) for asthma [57]
14.5 [13.6-15.4] n.a.
At least one of the following symptoms: wheeze in the last 12 months,
coughing constantly for more than 3 weeks in any time in your life,
attack of asthma in the last 12 months, or nasal allergies including
hay fever in the last 12 months [58]
n.a. 17.2 [16.5-17.9]‡‡
Wheeze in the last 12 months and at least 1 of the following in the last 12 months: any
lifetime episode of asthma; wheezing during physical exercise; four or more episodes of
wheezing in the previous year; or waking at night at least once a week due to wheezing [59]
n.a. 8.8 [8.3-9.3]††
Asthma in the last 12 months [60-66] n.a. n.a.
Had a condition which causes difficulty in breathing, with wheezing noises in
the chest in the last 12 months [67]
n.a. n.a.
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Table 1 Definitions of “current asthma” and prevalence estimates computed using data from INAsma survey (n = 6257)
and from NHANES 2009 (n = 10348) (Continued)
At least one of the following: 1) any symptom in the last 12 months: wheezing,
shortness of breath, coughing bouts or dyspnea or 2) previous physician-based
diagnosis of asthma or 3) use of medication for asthma [68]
n.a. n.a.
Both: 1) Ever whistling sound from chest or chest tightness or breathlessness
in the morning, and 2) having suffered from asthma or having an attack
of asthma in the past 12 months or using bronchodilators [69]
n.a. n.a.
Bronchial hyperresponsiveness and asthma symptoms (wheeze, night cough,
or shortness of breath at rest) within the previous 12 months [70]
n.a. n.a.
At least one of the following: 1) Recent symptoms (wheeze or nocturnal
cough) or 2) asthma medication use [71]
39.5 [38.2-40.7] n.a.
*Questions related to this variable were only asked in the second phase of INAsma; therefore the total number of participants was corrected for non-response in
phase II (total n = 4949). n.a. – not available – Questions related to this variable were not asked in the INAsma survey. †“Cough” was interpreted as “waking with
cough” for estimation purposes. ‡The variable was considered as “diagnosed with asthma by a physician and currently taking asthma medication and attacks of
asthma or wheeze in the last 12 months” for estimation purposes. ††The variable was considered without the symptom “any lifetime episode of asthma” for
estimation purposes. ‡‡The variable was considered without the symptom “attack of asthma in the last 12 months” for estimation purposes. **“ever had an asthma
attack” was considered as “ever had an asthma attack in the last 12 months” for estimation purposes.
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last 12 months: wheezing, waking with breathlessness or
having an asthma attack) of 6.8% for the Portuguese popu-
lation [9]. The INAsma survey comprised two phases: esti-
mation of the prevalence of current asthma and estimation
of the proportion of asthmatic patients with controlled dis-
ease. The INAsma survey and current study were reported
in accordance with the STrengthening the Reporting of
OBservational studies in Epidemiology (STROBE) state-
ment guidelines [11].
The National Health and Nutrition Examination Survey
(NHANES) 2005–2006 assessed the health and nutritional
status of the United States population. And estimated a
prevalence of asthma (defined as affirmative to the follow-
ing questions: 1) Has a doctor or other health professional
ever told you that you have asthma? 2) Do you still have
asthma?) of 8.8% for the U.S. population [12].
Further details on databases can be found in Additional
file 1.Data analysis
For each asthma definition recorded, we presented the cor-
responding prevalence value and 95% CI (if available) and
computed the proportion of individuals with asthma using
data from the INAsma survey and NHANES 2005–2006.
The definitions found were reproduced as they ap-
peared in each paper and were grouped into 3 general
subgroups: (i) current asthma (if the definition included
current asthma features such as symptoms, current use
of medication or the “still have asthma” expression); (ii)
diagnosed asthma (if the definition included an asthma
diagnosis by a health care professional or ever use of
medication for asthma, but not any current asthma fea-
ture) and (iii) lifetime asthma (if the definition included
having ever had asthma, but not any current asthma fea-
ture or asthma diagnosis).Statistical analyses were performed using IBM SPSS Sta-
tistics v21 (2012 SPSS Inc., IBM Company, Chicago, US).
The two phases of INAsma comprises data from 6 257 par-
ticipants, both males and females from 0 to 98 years old.
NHANES 2005–06 comprises data from 10 348 partici-
pants both males and females from 0 to 150 years old.
Using the two phases of INAsma and NHANES 2005–
2006 data, we estimated the proportion of individuals with
95% CI with asthma for each of the definitions in all applic-
able cases and when the necessary data were available.
The elements used in each paper to define current
asthma were plotted in a diagram (Figure 2). The size of
the circles is proportional to the number of definitions
in which the element is used. Different colors were at-
tributed to definition elements depending if they were
related to symptoms in the last 12 months, lung func-
tion tests or to physician diagnosis. Definitions elements
were connected in the sequence established by the def-
inition in each study. The number of times each con-
nection was used is also indicated.Results
Of the 1738 papers retrieved from the Web of Know-
ledge database, 117 were included for analysis (Figure 1).
The characteristics of the studies included are summa-
rized in Additional file 2 and 3. They described preva-
lence studies conducted all over the world, on children
(27.4%), on adolescents (10.3%), on children and adoles-
cents (25.6%), on adults (25.6%), on elders (1.7%) and
on all population(8.5%). Several questionnaires were
applied, but the most common one was the ISAAC
questionnaire, used in 45.5% of studies.
Lifetime asthma was defined in 34 papers, diagnosed
asthma in 54 and current asthma in 61 (see Additional
file 4). The 3 subgroups were defined in 8, 12 and 29
different ways, respectively (Tables 1 and 2).
Table 2 Definitions of “Lifetime asthma” and “Diagnosed asthma” and prevalence estimates computed using data
from INAsma survey (n = 6257) and from NHANES 2009 (n = 10348)
Definition INAsma NHANES 05/06
% [95% CI] % [95% CI]
Lifetime asthma
Ever had asthma [3,9,14,16,17,24,51,54,66,72-89] 14.5 [13.6-15.4] n.a.
Wheeze in the last 12 months or ever had asthma [90] 28.1 [27.0-29.2] n.a.
Had a condition which causes difficulty in breathing, with
wheezing noises in the chest [67]
n.a. n.a.
Self-report of dyspnea and nocturnal dyspnea associated with wheezing,
or attacks of dyspnea with wheezing, or physician-diagnosed asthma [91]
n.a. n.a.
Ever had wheeze [92] n.a. n.a.
Report of simultaneous dyspnea and wheezing in the absence of
upper respiratory infections [93]
9.5 [8.8-10.2] n.a.
Ever had wheeze and cough more than other (children) and
breathlessness at rest or exercise [94]
n.a. n.a.
Ever had asthma and/or one of the following: wheeze, cough or
acute shortness of breath due to external factors [95]
n.a. n.a.
Diagnosed asthma
Ever diagnosed with asthma by a physician or health
professional [21,23,24,26,28,29,52,66,85-88,91,92,94,96-118]
9.3 [8.5-10.2]* 13.4 [12.7-14.1]
Diagnosed with asthma by a physician or wheezing in the
last 12 months, apart from cold or the flu [119]
20.1 [19.0-21.2]* 24.5 [23.6-25.3]†
Diagnosed with asthma by a physician in the last 12 months [120,121] n.a. n.a.
Ever had asthma and medical confirmation [14,17,38,122] 9.3 [8.5-10.1]* n.a.
Ever had asthma and use of medication for asthma [9] 8.2 [7.5-8.9] n.a.
Ever diagnosed with asthma by a physician or health professional
and Ever stayed over night in the hospital for wheezing [123]
2.5 [2.1-2.9]* n.a.
Ever diagnosed with asthma by a physician or health professional
and use of medication for asthma [47]
7.4 [6.7-8.1]* 1.1 [0.9-1.3]
History of asthma and physical examination and skin-prick tests and
peak flow measurements [53]
n.a. n.a.
History of asthma and physical signs of asthma (rhonchi or chest deformity) [124] n.a. n.a.
Diagnosed with asthma by a physician or symptoms (presence of wheezing,
history of dry cough, recurrent wheeze, dyspnea/ recurrent difficulty in
breathing or recurrent chest tightness) with clinical assessment [125]
n.a. n.a.
Recurrent wheezing episodes, clinically confirmed by a physician, exactly
a pediatrician or a pediatric pulmonologist [126]
n.a. n.a.
Physician stated that (you) had asthma in the last 2 years, on 2 or more separate
occasions had wheezing in the last 2 years, or had asthma prior to 2 years ago
or on 2 or more separate occasions had wheezing prior to 2 years ago [39,40]
n.a. n.a.
*Questions related to this variable were only asked in the second phase of INAsma; therefore the total number of participants was corrected for non-response
in phase II (total n = 4949). n.a. – not available – Questions related to this variable were not asked in the INAsma survey. †“apart from cold or the flu” was not
considered for estimation purposes.
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on a combination of elements. The most common elements
were “wheeze in the last 12 months” (in 30 definitions) and
“ever diagnosed with asthma by a physician or health profes-
sional” (in 21 definitions) (Figure 2). “Current asthma treat-
ment” was used in 12 definitions. Other common symptoms
were “shortness of breath at rest” (n = 8), “asthma attack” (n
= 7), “shortness of breath/dyspnea” (n = 4), “nocturnal
cough” (n = 4) and “cough” (n = 3) in the last 12 months.Only 3 papers used “bronchial hyperresponsiveness” or “re-
versibility of airflow obstruction” in their definition of
asthma. The most common combination used to define
current asthma was “Ever diagnosed with asthma by a health
professional” together with “still have asthma” (n = 13).
Most of the papers using “wheeze in the last 12 months”
as an element to define current asthma described the
prevalence of asthma in children, adolescents or both (n =
21,70% - data not shown).
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plicable definitions of current asthma ranged between
5.3% and 39.5% in the Portuguese population for the 13
(45%) applicable definitions and between 1.1% and
17.2% in U.S. population for the 7(24%) applicable defi-
nitions (Table 1).
The definitions varied even in papers that used the same
questionnaire. For instance, eight different definitions
were used in 18 studies of the ISAAC questionnaire (see
Additional file 5 and Figure 3). Using the eight variants of
the definition of current asthma based on the ISAAC
questionnaire, the proportion of children and adolescents
with asthma estimated from the INAsma data varied be-
tween 9.0% and 20.5% (Figure 3).
Concerning definitions of lifetime asthma, three defini-
tions could be used with data from INAsma with preva-
lence estimates ranging between 9.5% and 28.1%; none of
the definitions were applicable to NHANES data (Table 2).
Discussion
The operational definitions of asthma varied extensively
among studies and do not allow to compare estimates
between studies, even if similar data collection methods
were used. Additionally, when we applied the definitions
of current asthma to two datasets from population stud-
ies, we found that the prevalence of asthma ranged from
5.3% to 39.5% in Portuguese population and from 1.1%
to 17.2% in U.S. population depending on the definition
used. Current asthma was most frequently defined byFigure 3 Prevalence of asthma according to several definitions of the
estimates for Portuguese children aged 6, 7, 13 and 14 years old were com
*95% CI not available. n.a. – not available. Proportion of people with asthm
other studies are represented by ■. Lines represent the CI (when available)the combination of “ever diagnosed with asthma by a
health professional” with “still having asthma”. Wheeze
was the most frequently used current symptom, espe-
cially in children.
The Web of Knowledge was the only database used
for the search. While this may be seen as a limitation of
the present study, this approach allowed the inclusion of
the most-cited papers on asthma prevalence conducted
in both children and adults.
The wide variability of the estimates computed for differ-
ent definitions is in accordance with the results of a study
in children [5]. The variety of definitions identified in the
present study illustrates both the difficulty of identifying
people with asthma by questionnaire and the difficulty of
establishing an internationally accepted definition, even
when the same questionnaire is used.
The few published studies that have validated asthma
questionnaires, used BHR tests or a physician’s diagnosis
as gold-standard [8,127,128]. These reports concluded that
questions on wheeze are the most sensitive and questions
such as “Have you ever had asthma?” or questions on
“waking with attacks of shortness of breath” and “morning
tightness” have high specificity for asthma [8,127,128]. In
our review, wheeze was the most commonly used symp-
tom, especially in children. However, it should be noted
that a diagnosis of asthma based on wheeze is only accur-
ate during some stages of childhood [129,130] and the use
of a comprehensive description of asthma symptoms
might reduce the risk of misclassification of asthma in“Current asthma” based on ISAAC questionnaire. Prevalence
puted using data from the INAsma survey (also see Additional file 5).
a using the INAsma data are represented by •; prevalence stated in
. Shades gather the values for the same definition.
Figure 4 Questions to be asked and independently reported.
Sá-Sousa et al. Clinical and Translational Allergy 2014, 4:24 Page 8 of 12
http://www.ctajournal.com/content/4/1/24children. Pekkanen and coworkers also suggested that def-
initions using a combination of asthma symptoms increase
specificity against self-report of ever having asthma and
BHR and that the use of a continuous asthma score based
on asthma symptoms increases both the specificity and
power for predicting asthma [7].
The present study shows that prior asthma diagnosis by a
health professional was commonly used to define asthma.
However, in some countries and cultural contexts, the useof prior diagnosis may lead to an under- or overestimation
of asthma prevalence [131]. Attention to this potential
problem is especially important in multinational studies
and, in fact, ISAAC [3] and ECRHS [2] do not consider a
prior diagnosis definitive for asthma.
Standardized definitions are necessary for prevalence
comparisons worldwide. This should be achieved by the
validation of self-reported features, against objective meas-
ure, such as (i) variability of airflow obstruction, reversibility
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therapy and (iii) persistence of diagnosis at clinical long-
term follow-up. By reporting the sensitivity and specificity
of different approaches, these validation studies would in-
form the decision on a standardized operational definition
of asthma for epidemiological purposes.
Based on the data presented, we propose an initial
comprehensive set of questions (Figure 4) that can be
used in validation studies while allowing comparisons
with previous prevalence studies of asthma. As this is
an early step to achieve a standardized definition of
asthma, we suggest that at this time, the data items pro-
posed in Figure 4 should be reported separately to in-
crease the inter-study comparability.Conclusions
The operational definition of asthma has an important
effect on estimates of asthma prevalence in epidemio-
logic studies. There is a need for an accurate standard-
ized operational definition of asthma. To inform this
definition it is important to estimate the sensibility and
specificity of a set of questions (Figure 4) against re-
versibility/variability of the airflow obstruction, BHR
and clinical assessment.Additional files
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